HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mohammad Nasehi Selected Research
Mohammad Nasehi Research Topics
Disease
32
Amnesia (Dissociative Amnesia)
06/2021 - 10/2009
19
Memory Disorders (Memory Loss)
06/2021 - 01/2013
15
Sleep Deprivation
02/2022 - 01/2016
12
Cholestasis
10/2021 - 11/2011
4
Cognitive Dysfunction
04/2022 - 11/2013
4
Hepatic Encephalopathy
12/2020 - 02/2013
4
Pain (Aches)
01/2020 - 09/2017
3
B-Cell Lymphoma (Lymphoma, B Cell)
08/2021 - 01/2020
3
Alzheimer Disease (Alzheimer's Disease)
03/2021 - 04/2014
2
Stroke (Strokes)
04/2022 - 01/2020
2
Multiple Sclerosis
04/2022 - 02/2020
2
Mental Disorders (Mental Disorder)
01/2022 - 01/2020
2
Inflammation (Inflammations)
12/2020 - 01/2017
1
Necrosis
06/2022
1
Autism Spectrum Disorder
06/2022
1
Schizophrenia (Dementia Praecox)
04/2022
1
Neuroinflammatory Diseases
10/2021
1
Ischemic Stroke
07/2021
1
Sleep Wake Disorders
10/2020
1
Substance-Related Disorders (Drug Abuse)
06/2020
1
Hyperalgesia
01/2019
1
Autistic Disorder (Autism)
05/2018
1
Neurodevelopmental Disorders
05/2018
Drug/Important Bio-Agent (IBA)
8
harman (harmane)
IBA
09/2019 - 05/2010
7
SCH 23390
IBA
01/2021 - 02/2013
7
Sulpiride (neogama)
IBA
01/2021 - 02/2013
7
Anti-Anxiety Agents (Anxiolytics)
IBA
10/2017 - 11/2011
7
Naloxone (Narcan)
FDA Link
Generic
10/2016 - 11/2011
6
Cannabinoids
IBA
01/2021 - 01/2015
6
CB1 Cannabinoid Receptor (CB1 Receptor)
IBA
02/2016 - 10/2009
5
Neuroaid
IBA
08/2021 - 01/2019
5
RS 67333
IBA
06/2021 - 03/2014
5
Scopolamine (Hyoscine)
FDA Link
01/2021 - 03/2012
5
Morphine (MS Contin)
FDA Link
Generic
06/2020 - 03/2012
5
Opioid Analgesics (Opioids)
IBA
01/2019 - 11/2011
5
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
05/2017 - 10/2011
4
Dopamine Antagonists
IBA
01/2021 - 08/2013
4
5-HT4 Serotonin Receptors
IBA
01/2020 - 03/2014
4
Pharmaceutical Preparations
IBA
01/2018 - 10/2009
4
Dopamine (Intropin)
FDA Link
Generic
08/2013 - 05/2010
3
Therapeutic Uses
IBA
04/2022 - 02/2020
3
Antioxidants
IBA
10/2021 - 06/2020
3
salicylhydroxamic acid (SHAM)
IBA
03/2021 - 06/2013
3
AM 251 (AM251)
IBA
01/2021 - 10/2009
3
Muscimol
IBA
01/2018 - 01/2015
3
Cholinergic Agents (Cholinergics)
IBA
10/2017 - 03/2012
3
azasetron
IBA
09/2017 - 03/2014
3
Dizocilpine Maleate (Dizocilpine)
IBA
04/2016 - 10/2011
3
mu Opioid Receptors (mu Opioid Receptor)
IBA
04/2014 - 06/2013
3
N-Methylaspartate (NMDA)
IBA
11/2013 - 10/2011
3
NG-Nitroarginine Methyl Ester (L-NAME)
IBA
06/2013 - 03/2012
2
Thimerosal (Thiomersal)
IBA
06/2022 - 05/2018
2
crocin
IBA
10/2021 - 06/2021
2
Proteins (Proteins, Gene)
FDA Link
08/2021 - 01/2020
2
Brain-Derived Neurotrophic Factor (BDNF)
IBA
06/2021 - 01/2019
2
Yohimbine (Yocon)
IBA
01/2020 - 01/2016
2
Clonidine (ST 155)
FDA Link
Generic
01/2020 - 01/2016
2
Dopamine Agents (Dopaminergic Agents)
IBA
09/2019 - 10/2012
2
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
10/2017 - 04/2014
2
Alkaloids
IBA
12/2016 - 05/2010
2
Adrenergic Receptors (Adrenergic Receptor)
IBA
01/2016 - 01/2016
2
arachidonylcyclopropylamide
IBA
11/2015 - 04/2015
2
Harmaline
IBA
07/2015 - 10/2014
2
Arginine (L-Arginine)
FDA Link
06/2013 - 01/2013
1
Immunologic Factors (Immunomodulators)
IBA
02/2022
1
Epitopes
IBA
02/2022
1
Lithium
IBA
01/2022
1
Catalase
IBA
10/2021
1
Superoxide Dismutase
IBA
10/2021
1
punicalagin
IBA
03/2021
1
Inflammation Mediators
IBA
03/2021
1
Lithium Chloride
IBA
01/2021
1
Amyloid (Amyloid Fibrils)
IBA
12/2020
1
bcl-2-Associated X Protein (bcl 2 Associated X Protein)
IBA
12/2020
1
mitochondrial transcription factor A
IBA
12/2020
1
propionic acid (potassium propionate)
IBA
12/2020
1
Curcumin
IBA
12/2020
1
alpha-2 Adrenergic Receptors
IBA
12/2020
1
Oxidoreductases (Dehydrogenase)
IBA
10/2020
1
Cocaine (Cocaine HCl)
IBA
06/2020
1
Neuroprotective Agents
IBA
06/2020
1
Neuropeptides
IBA
06/2020
1
Amphetamine (Amfetamine)
FDA Link
Generic
06/2020
1
Free Radicals
IBA
01/2020
1
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
01/2020
1
Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
IBA
01/2020
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)
IBA
09/2019
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2019
1
Streptozocin (Streptozotocin)
FDA Link
01/2019
1
Opiate Alkaloids
IBA
01/2019
1
Dopamine D2 Receptor Antagonists
IBA
01/2019
1
Dopamine Receptors (Dopamine Receptor)
IBA
01/2019
Therapy/Procedure
12
Ligation
10/2021 - 11/2011
5
Injections
09/2019 - 10/2009
4
Transcranial Direct Current Stimulation
01/2021 - 11/2017
4
Analgesia
01/2019 - 09/2017
3
Cognitive Training
04/2022 - 01/2020
1
Activities of Daily Living (ADL)
01/2020
1
Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019